Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.

DeepDyve requires Javascript to function. Please enable Javascript on your browser to continue.

Carmo-Pereira, J; Costa, F O; Henriques, E

European journal of cancer , Volume 16 (12): -1615 – Jul 9, 1981

Download PDF

Carmo-Pereira, J; Costa, F O; Henriques, E

European journal of cancer , Volume 16 (12): -1615 – Jul 9, 1981

Loading next page...

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Combination vs. single drug therapy in advanced breast cancer

Lemkin
Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination

Rubens
Combination chemotherapy for metastatic breast carcinoma

Canellos
Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer

Mouridsen
The chemical therapy of breast cancer

Carter
The clinical evaluation of chemotherapeutic agents in the treatment of neoplastic diseases

Karnofsky
Assessment of response to therapy in advanced breast cancer

Hayward
Design and analysis of randomized clinical trials requiring prolonged observations of each patient. II. Analysis and examples

Peto
Vincristine treatment of advanced cancer: a cooperative study of 392 cases

Holland
Perspectives in the treatment of breast cancer: 1976

Young
Five-drug therapy in advanced breast cancer—factors influencing toxicity and response

Davis
Response of metastatic breast cancer to combination chemotherapy according to site

Russel
Phase II study of combination cytotoxic chemotherapy in advanced breast cancer: 2 years ‘followup’

Carmo-Pereira